CPG
DGX icon

Cornerstone Planning Group’s Quest Diagnostics DGX Stock Holding History

Cornerstone Planning Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.8K Buy
90
+5
+6% +$981 ﹤0.01% 693
2026
Q1 		$16.1K Buy
85
+18
+27% +$3.5K ﹤0.01% 740
2025
Q4 		$12.3K Buy
67
+63
+1,575% +$11.5K ﹤0.01% 740
2025
Q3 		$71 Sell
4
-41
-91% -$7.28K ﹤0.01% 1665
2025
Q2 		$7.81K Buy
45
+5
+13% +$868 ﹤0.01% 618
2025
Q1 		$6.94K Buy
40
+25
+167% +$4.11K ﹤0.01% 649
2024
Q4 		$2.4K Buy
+15
New +$2.33K ﹤0.01% 745

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Cornerstone Planning Group's DGX Position: Q2 2026 in Review

Cornerstone Planning Group increased its Quest Diagnostics (DGX) stake by 5.9% in Q2 2026, buying an estimated $981 and bringing the position to 90 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #693.

Cornerstone Planning Group first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 678 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Cornerstone Planning Group held 90 shares of Quest Diagnostics worth $18.8K as of Q2 2026.
  • Cornerstone Planning Group bought 5 Quest Diagnostics shares in Q2 2026, an estimated $981.
  • Quest Diagnostics made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #693 holding.
  • Cornerstone Planning Group first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 678 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.